His scientific interests lie mostly in Immunology, Arthritis, Type II collagen, FOXP3 and T cell. He combines subjects such as Autoimmune disease, Antibody and B cell with his study of Arthritis. David D. Brand has included themes like Glutaraldehyde, Molecular biology, Rheumatoid arthritis and Carbodiimide in his Type II collagen study.
David D. Brand interconnects Adjuvant, Immunization, Cyanogen bromide and Disease in the investigation of issues within Rheumatoid arthritis. His FOXP3 research includes elements of Cell, IL-2 receptor, Cellular differentiation, Transforming growth factor beta and Retinoic acid. David D. Brand studied T cell and Major histocompatibility complex that intersect with Immunodominance.
David D. Brand focuses on Immunology, Arthritis, Type II collagen, T cell and FOXP3. Immunology is closely attributed to In vivo in his study. He has researched Arthritis in several fields, including Molecular biology, Cytokine, Autoimmune disease and Recombinant DNA.
His biological study deals with issues like Biochemistry, which deal with fields such as Biophysics. His FOXP3 research is multidisciplinary, relying on both Cell, Cancer research, IL-2 receptor, Cell biology and Transforming growth factor beta. The study incorporates disciplines such as Inflammation, Disease and Transgene in addition to Rheumatoid arthritis.
Immunology, Arthritis, Internal medicine, T cell and Cell biology are his primary areas of study. His study focuses on the intersection of Immunology and fields such as Cytotoxic T cell with connections in the field of Peptide binding and Major histocompatibility complex. His study in the fields of Type II collagen under the domain of Arthritis overlaps with other disciplines such as Congenic breeding.
His studies in Type II collagen integrate themes in fields like Extracellular matrix and In vivo. His work in Internal medicine addresses issues such as Endocrinology, which are connected to fields such as Angiotensin II and Angiotensin receptor. His work on T-cell receptor as part of general T cell research is frequently linked to Syk, bridging the gap between disciplines.
The scientist’s investigation covers issues in Immunology, Cell biology, FOXP3, Cellular differentiation and Cancer research. His Immunology study combines topics in areas such as Periodontal disease and Rheumatology. His Cell biology study incorporates themes from Tissue engineering, In vitro and Type II collagen.
The various areas that David D. Brand examines in his FOXP3 study include Transforming growth factor beta, Tretinoin, Retinoic acid and CD8. The concepts of his Cellular differentiation study are interwoven with issues in Autoantibody, Autoimmunity, B-cell activating factor and Immunoglobulin class switching. His Cancer research research incorporates themes from Biomarker, Downregulation and upregulation, Long non-coding RNA and Tumor necrosis factor alpha.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
David D Brand;David D Brand;Kary A Latham;Kary A Latham;Edward F Rosloniec;Edward F Rosloniec.
Nature Protocols (2007)
IL-17–dependent cellular immunity to collagen type V predisposes to obliterative bronchiolitis in human lung transplants
William J. Burlingham;Robert B. Love;Robert B. Love;Ewa Jankowska-Gan;Lynn D. Haynes.
Journal of Clinical Investigation (2007)
Immunopathogenesis of collagen arthritis.
David D. Brand;Andrew H. Kang;Edward F. Rosloniec.
Springer Seminars in Immunopathology (2003)
An HLA-DR1 Transgene Confers Susceptibility to Collagen-induced Arthritis Elicited with Human Type II Collagen
Edward F. Rosloniec;David D. Brand;Linda K. Myers;Karen B. Whittington.
Journal of Experimental Medicine (1997)
Cross-linking electrospun type II collagen tissue engineering scaffolds with carbodiimide in ethanol.
Catherine P. Barnes;Charles W. Pemble;David D. Brand;David G. Simpson.
Tissue Engineering (2007)
Cutting Edge: All-Trans Retinoic Acid Sustains the Stability and Function of Natural Regulatory T Cells in an Inflammatory Milieu
Xiaohui Zhou;Ning Kong;Ning Kong;Julie Wang;Huiming Fan.
Journal of Immunology (2010)
Anti-type V collagen lymphocytes that express IL-17 and IL-23 induce rejection pathology in fresh and well-healed lung transplants.
S. Yoshida;A. Haque;T. Mizobuchi;T. Iwata.
American Journal of Transplantation (2006)
Cleavage of denatured natural collagen type II by neutrophil gelatinase B reveals enzyme specificity, post-translational modifications in the substrate, and the formation of remnant epitopes in rheumatoid arthritis
Philippe Van den Steen;Paul Proost;Bernard Grillet;David D Brand.
The FASEB Journal (2002)
Adoptive Transfer of Human Gingiva‐Derived Mesenchymal Stem Cells Ameliorates Collagen‐Induced Arthritis via Suppression of Th1 and Th17 Cells and Enhancement of Regulatory T Cell Differentiation
Maogen Chen;Wenru Su;Xiaohong Lin;Zhiyong Guo.
Arthritis & Rheumatism (2013)
Edward F. Rosloniec;Michael Cremer;Andrew H. Kang;Linda K. Myers.
Current protocols in immunology (1996)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: